Antonello Bellomo Selected Research

vabicaserin

10/2021

New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonello Bellomo Research Topics

Disease

17	Schizophrenia (Dementia Praecox) 10/2023 - 03/2003
14	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2016
13	Cognitive Dysfunction 04/2024 - 01/2017
10	Dementia (Dementias) 01/2023 - 10/2017
7	Psychotic Disorders (Schizoaffective Disorder) 10/2023 - 03/2003
6	Frailty 01/2023 - 10/2017
5	Bipolar Disorder (Manic Depressive Psychosis) 10/2023 - 12/2016
5	Mental Disorders (Mental Disorder) 05/2023 - 12/2016
4	Neurobehavioral Manifestations 04/2023 - 01/2018
4	Depressive Disorder (Melancholia) 01/2021 - 01/2018
3	Inflammation (Inflammations) 12/2023 - 01/2020
2	Neuroinflammatory Diseases 04/2024 - 08/2022
2	Disease Progression 04/2024 - 12/2016
2	Tauopathies 07/2023 - 01/2023
2	Substance-Related Disorders (Drug Abuse) 01/2023 - 12/2016
2	Treatment-Resistant Depressive Disorder 12/2022 - 01/2018
2	Frontotemporal Dementia (Semantic Dementia) 01/2019 - 01/2016
2	Drug-Related Side Effects and Adverse Reactions 09/2018 - 12/2016
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 07/2023
1	AIDS-Related Complex (ARC) 04/2023
1	Neurodevelopmental Disorders 04/2023
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2023
1	Autistic Disorder (Autism) 04/2023
1	Amyloid Plaque 08/2022
1	Neoplasms (Cancer) 06/2022
1	Heart Failure 01/2022
1	Poisoning 01/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2019
1	Hearing Loss (Hearing Impairment) 01/2019
1	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2019
1	Aphasia (Dysphasia) 01/2019
1	Panic Disorder (Panic Attack) 12/2018

Drug/Important Bio-Agent (IBA)

11	Antipsychotic Agents (Antipsychotics)IBA 12/2022 - 10/2004
9	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2016
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2018 - 12/2016
3	Peptides (Polypeptides)IBA 01/2023 - 11/2019
3	AntioxidantsIBA 10/2021 - 01/2018
2	Monoclonal AntibodiesIBA 04/2024 - 07/2023
2	solanezumabIBA 04/2024 - 01/2018
2	Apolipoproteins E (ApoE)IBA 12/2023 - 12/2022
2	ApolipoproteinsIBA 12/2023 - 01/2023
2	Carrier Proteins (Binding Protein)IBA 07/2023 - 01/2023
2	Amyloidogenic ProteinsIBA 07/2023 - 12/2016
2	Antidepressive Agents (Antidepressants)IBA 04/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2022
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021 - 12/2017
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 12/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 01/2017
2	Olanzapine (Zyprexa)FDA Link 10/2004 - 08/2004
1	tau Proteins (tau Protein)IBA 04/2024
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 10/2023
1	Polytetrafluoroethylene (Teflon)FDA Link 10/2023
1	AntibodiesIBA 07/2023
1	agomelatine (S20098)IBA 04/2023
1	peptide 021IBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	OligonucleotidesIBA 01/2023
1	cariprazineIBA 01/2023
1	Antisense OligonucleotidesIBA 01/2023
1	Lurasidone Hydrochloride FDA Link 12/2022
1	EsketamineIBA 12/2022
1	aducanumabIBA 08/2022
1	Ibuprofen (Motrin)FDA LinkGeneric 08/2022
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 08/2022
1	Fumigant 93 (D-D)IBA 06/2022
1	CytokinesIBA 01/2022
1	vabicaserinIBA 10/2021
1	Lipid PeroxidesIBA 10/2021
1	Memantine (Namenda)FDA Link 10/2021
1	OxidesIBA 10/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 10/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2021
1	Glutathione (Reduced Glutathione)IBA 10/2021
1	Erythropoietin FDA Link 10/2021
1	Cycloserine (Seromycin)FDA Link 10/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2021
1	N-Methylaspartate (NMDA)IBA 10/2021
1	purineIBA 10/2021
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	SDMIBA 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Salivary alpha-AmylasesIBA 12/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2018

Therapy/Procedure

8	Therapeutics 04/2024 - 01/2019
7	Secondary Prevention 08/2022 - 10/2017
2	Institutionalization (Institutionalized Persons) 01/2023 - 01/2020
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2021 - 01/2019
2	Patient Readmission 09/2018 - 12/2016
1	Immunotherapy 07/2023
1	Transitional Care 05/2023
1	Injections 11/2021
1	Treatment Delay 10/2021
1	Fecal Microbiota Transplantation 01/2020